VIPERGEN
Vipergen ApS is a biotechnology company dedicated to small molecule drug discovery using DNA-encoded chemical library technologies. Vipergen seeks to leverage its proprietary drug discovery technologies in partnerships with pharmaceutical and biotech companies keen on tackling the most challenging protein targets for important unmet medical needs.
VIPERGEN
Social Links:
Industry:
Biotechnology
Founded:
2005-01-01
Address:
Copenhagen, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.vipergen.com
Total Employee:
11+
Status:
Active
Contact:
+45 2523 6680
Email Addresses:
[email protected]
Technology used in webpage:
Domain Not Resolving Google Maps Mobile Non Scaleable Content ReCAPTCHA Cloudflare JS CDN JS U.S. Server Location Apple Mobile Web App Capable ReCAPTCHA V2 Apple Mobile Web App Status Bar Style
Similar Organizations
Official Site Inspections
http://www.vipergen.com Semrush global rank: 3.79 M Semrush visits lastest month: 3.15 K
- Host name: static.52.152.9.176.clients.your-server.de
- IP address: 176.9.152.52
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin

More informations about "Vipergen"
Who is Vipergen? Read all about us and drug discovery here
Vipergen is a world leading provider of small molecule drug discovery services based on DNA-encoded library (DEL) technologies. Vipergen offers to current and future partners to discover โฆSee details»
Vipergen - Crunchbase Company Profile & Funding
Vipergen ApS is a biotechnology company dedicated to small molecule drug discovery using DNA-encoded chemical library technologies. Vipergen seeks to leverage its proprietary drug โฆSee details»
Drug Discovery Services - Get an early lead | Vipergen
Vipergen is a trusted partner for outsourced early-stage drug discovery. Our drug discovery services provide pharmaceutical and biotech companies with access to innovative screening โฆSee details»
Vipergen - Lab Manager
Vipergen Vipergen is a world-leading provider of small-molecule drug discovery services based on DNA-encoded library (DEL) technologies and is the first and only company capable of โฆSee details»
Vipergen Company Profile | Management and Employees List
Vipergen Profile and History Vipergen is a world-leading provider of small-molecule drug discovery services based on DNA-encoded library (DEL) technologies and is the first and only โฆSee details»
Vipergen ApS - LinkedIn
Vipergen is a world leading provider of small molecule drug discovery services based on DNA-encoded library (DEL) technologies. Vipergen is finding tractable hits/leads for your pharmaceutical ...See details»
Vipergen Company Profile - Office Locations, Competitors ... - Craft
Vipergen has 5 employees at their 1 location. See insights on Vipergen including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Vipergen - VentureRadar
Vipergen ApS is a biotechnology company dedicated to small molecule drug discovery using DNA-encoded chemical library technologies. Vipergen seeks to leverage its proprietary drug โฆSee details»
Vipergen - Products, Competitors, Financials, Employees, โฆ
Hyderabad, India, and Copenhagen, Denmark; April 19, 2024: Aurigene Pharmaceutical Services Ltd. (Aurigene), a global contract research, development, and manufacturing services โฆSee details»
Vipergen ApS - Drug pipelines, Patents, Clinical trials - Synapse
Vipergen ApS is a biotech firm that specializes in utilizing DNA-encoded chemical library technologies for small molecule drug discovery. The company aims to collaborate with โฆSee details»
Vipergen's Resource Guides | Lab Manager
Vipergen is a world-leading provider of small-molecule drug discovery services based on DNA-encoded library (DEL) technologies and is the first and only company capable of screening โฆSee details»
Vipergen | CipherBio
Explore Vipergen's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Contact Vipergen today for an inquiry
Vipergen stands as a pioneer in the biotech and pharmaceutical industry, driven by a commitment to innovation and excellence. Our team of highly qualified professionals brings together โฆSee details»
Vipergen Publishes First Technology for Screening DNA-Encoded โฆ
Mar 1, 2021 Vipergen is a world-leading provider of small-molecule drug discovery services based on DNA-encoded library (DEL) technologies and is the first and only company capable โฆSee details»
Aurigene Pharmaceutical Services Ltd., and Vipergen announce a ...
Apr 19, 2024 Aurigene Pharmaceutical Services Ltd. (Aurigene), a global contract research, development, and manufacturing services organization (CRDMO), and Vipergen ApS, a niche โฆSee details»
DNA-Encoded Library Screening For Drug Discovery
Nov 11, 2024 SARomics Biostructures and Vipergen offer hit and lead identification services based on Vipergenโs DNA-encoded library screening technology.See details»
We present 3 technologies for DNA encoded libraries (DEL)
Vipergen presents three technologies for DNA encoded libraries (DEL) which together deliver the highest fidelity drug discovery capabilities. The YoctoReactor (yR) technology creates vast โฆSee details»
DNA organization offers clues for advancing stem cell therapy
3 days ago Scientists at the University of California, Riverside, have discovered how adult stem cells retain their regenerative power. The researchers demonstrate in a paper published in the โฆSee details»
Resources - vipergen
Jun 7, 2018 Aurigene Pharmaceutical Services Ltd., and Vipergen announce a strategic partnership for offering DNA encoded library (DEL) screening and integrated drug discovery โฆSee details»
Get an overview of all Vipergen news here
Get an overview of all Vipergen news. Visit the page for more news and information.See details»